Fusion proteins for treatment of cancer

Porgador Angel

Fusion proteins for treatment of cancer

Porgador Angel (Inventor)

The Shraga Segal Department of Microbiology and Immunology

Ben-Gurion University of the Negev

Research output: Patent

Abstract

Chimeric polypeptides comprising a first moiety comprising an NKp44-derived peptide fused to a second moiety comprising one or more cell penetrating peptides (CPP), and polynucleotides encoding the same. Further provided are methods for treating, or ameliorating cancer.

Original language	American English
Patent number	IL249610
Priority date	15/12/16
State	Published - 31 Dec 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{13f53c0f5c0c499c9b0efad3774f22a4,

title = "Fusion proteins for treatment of cancer",

abstract = "Chimeric polypeptides comprising a first moiety comprising an NKp44-derived peptide fused to a second moiety comprising one or more cell penetrating peptides (CPP), and polynucleotides encoding the same. Further provided are methods for treating, or ameliorating cancer.",

author = "Porgador Angel",

year = "2017",

month = dec,

day = "31",

language = "American English",

type = "Patent",

note = "IL249610",

}

TY - PAT

T1 - Fusion proteins for treatment of cancer

AU - Angel, Porgador

PY - 2017/12/31

Y1 - 2017/12/31

N2 - Chimeric polypeptides comprising a first moiety comprising an NKp44-derived peptide fused to a second moiety comprising one or more cell penetrating peptides (CPP), and polynucleotides encoding the same. Further provided are methods for treating, or ameliorating cancer.

AB - Chimeric polypeptides comprising a first moiety comprising an NKp44-derived peptide fused to a second moiety comprising one or more cell penetrating peptides (CPP), and polynucleotides encoding the same. Further provided are methods for treating, or ameliorating cancer.

M3 - Patent

M1 - IL249610

ER -